Home > Products > CD16 & GD2
> Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG)
Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-037)
Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD16 and anti-GD2 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
There are currently no customer reviews or questions for Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) (BSIG-037). Click the button below to contact us or submit your feedback about this product.